Background Dyspnea that is refractory to conventional treatments affects up to 50% of
patients with advanced chronic obstructive pulmonary disease (COPD). Although …

Objective To explore the experiences of family physicians and respiratory therapists in
treating advanced chronic obstructive pulmonary disease (COPD) and their attitudes to the …

Chronic obstructive pulmonary disease (COPD) will be the third leading cause of death
worldwide by 2020. The burdens of this increasingly prevalent illness borne by patients …

Opioids for palliation of refractory dyspnea in chronic obst... : Current Opinion in Pulmonary
Medicine Opioids for palliation of refractory dyspnea in chronic obstructive pulmonary disease …

Background: A recent national practice guideline recommends the use of opioids for the
treatment of refractory dyspnea in patients with advanced chronic obstructive pulmonary …

Dyspnea is a cardinal symptom of chronic obstructive pulmonary disease (COPD), and its
severity and magnitude increases as the disease progresses, leading to significant disability …

Background: Opioids are recommended to treat advanced refractory dyspnoea despite
optimal therapy by the American Thoracic Society clinical practice guidelines, while newly …

Background Low-dose opioids can relieve breathlessness but may be underused in late-
stage COPD due to fear of complications, contributing to poor symptom control. Objectives …

PURPOSE: Patients with advanced COPD usually suffer from progressive dyspnea.
Dyspnea defies conventional treatment for 50% patients. Opioids have been advocated as a …

Background: Opioids are commonly used to treat dyspnoea in palliative medicine but there
has been no formal evaluation of the evidence for their effectiveness in the treatment of …